Clinical Trials Directory

Trials / Sponsors / PegBio Co., Ltd.

PegBio Co., Ltd.

Academic / Other · 15 registered clinical trials.

StatusTrialPhaseStarted
CompletedA Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of PB-119 Injection in Chinese Obese Subjec
Obesity
Phase 1 / Phase 22024-05-27
CompletedA Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of PB-718 Injection in Chinese Obese Subjec
Obesity
Phase 1 / Phase 22023-07-06
UnknownStudy to Evaluate the Efficacy and Safety of PB-201 in Type 2 Diabetic Mellitus Patients With Poor Glycemic Co
Type 2 Diabetes Mellitus
Phase 32022-05-30
UnknownStudy to Evaluate the Pharmacokinetic Characteristics of Pegylated Exenatide Injection (PB-119) in Subjects Wi
Type2Diabetes
Phase 12022-05-01
UnknownStudy to Evaluate the Safety and Efficacy of PB-201 in Treatment-naive Patients With Type 2 Diabetes Mellitus
Type 2 Diabetes Mellitus (T2DM)
Phase 32021-09-30
CompletedA Phase 1, Double-blind, Randomized, Placebo-controlled, Single- and Multiple-dose Escalating Study
Healthy Subjects
Phase 12020-07-29
CompletedSafety and Efficacy of PB-119 in Subjects With Type 2 Diabetes and Not Well-controlled by Metformin Monotherap
Type 2 Diabetes Mellitus (T2DM)
Phase 32020-06-23
CompletedSafety and Efficacy of Pegylated Exenatine Injection (PB-119) in Drug-naïve T2DM Subjects
Type 2 Diabetes Mellitus (T2DM)
Phase 32020-04-27
CompletedClinical Trial for the Investigational Drug (PB-201) in Subjects With Type 2 Diabetes Mellitus
Type2 Diabetes Mellitus
Phase 12019-08-27
CompletedDose-finding of PB-119 Administered Subcutaneously Once Weekly Versus Placebo in Subjects With Type 2 Diabetes
Type 2 Diabetes Mellitus (T2DM)
Phase 22018-06-13
CompletedDose-finding of PB-119 Administered Subcutaneously Once-weekly Versus Placebo in Drug-naïve T2DM Subjects
Type 2 Diabetes Mellitus
Phase 22018-06-05
CompletedMAD Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PB-119 to Subjects Wi
Type2 Diabetes Mellitus
Phase 12015-11-24
CompletedClinical Trial for PB-119 in Subjects With Type 2 Diabetes Mellitus
Type II Diabetes Mellitus
Phase 12015-04-08
CompletedContinuous Multiple Dose PB-119 Injection in Health Volunteers
Type2 Diabetes Mellitus
Phase 12014-11-15
CompletedClinical Trial for PB-119 in Healthy Subjects (Phase I)
Type II Diabetes
Phase 12014-02-01